JRDG:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) GBX (GBX)

ETF | Others |

Last Closing

USD 3833.75

Change

-14.00 (-0.36)%

Market Cap

N/A

Volume

2.76K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.99 (+0.74%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+0.50 (+0.25%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.43 (+2.45%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.36%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.10%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

-1.60 (-1.41%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 218.91B
0QZ3:LSE Qualcomm Inc.

+2.06 (+1.27%)

USD 202.26B

ETFs Containing JRDG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.18% 78% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.18% 78% C+ 75% C
Trailing 12 Months  
Capital Gain 23.23% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.23% 75% C 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.38% 62% D 66% D+
Dividend Return 9.38% 61% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.88% 68% D+ 81% B-
Risk Adjusted Return 94.94% 90% A- 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike